Rovira, R, Mereu, L, Planchamp, F, Falconer, H, El-Balat, A, Barahona, M, Fagotti, A, Querleu, D, Taskiran, C. ESGE/ESGO/SERGS consensus statement on surgical steps in minimally invasive surgery in gynecologic oncology: transperitoneal and extraperitioneal approach for paraaortic lymphadenectomy. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2024; DOI:10.1136/ijgc-2024-005796. PMID:39317443. IF:4.700(Q1/1D).

Perez-Fidalgo, JA, Gálvez-Montosa, F, Guerra, EM, Madariaga, A, Manzano, A, Martin-Lorente, C, Rubio-Pérez, MJ, Alarcón, J, Barretina-Ginesta, MP, Gaba, L. SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023). Clinical & Translational Oncology. 2024; 26(11)DOI:10.1007/s12094-024-03531-3. PMID:39008159. IF:2.500(Q3/6D).

Tapia, JC, Bosma, F, Gavira, J, Sanchez, S, Molina, MA, Sanz-Beltran, J, Martin-Lorente, C, Anguera, G, Maroto, P. Treatment Patterns and Survival Outcomes Before and After Access to Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma: A Single-Center Retrospective Study From 2004 to 2021. Clinical Genitourinary Cancer. 2024; 22(3)DOI:10.1016/j.clgc.2024.01.019. PMID:38430859. IF:2.700(Q2/3D).

Edwards, MC, Caruana, P, Fernández, R, Martin-Lorente, C, Teixeira, N, Muñoz, R, Llurba, E, Corchero, JL, Céspedes, MV. Validating organotypic tumour slice culture as a 3D drug evaluation platform for high-grade gynaecological cancers. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).